Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.00%6.88B | 2.70%29.22B | -1.40%7.72B | -6.74%7.19B | 8.12%7.43B | 13.90%6.88B | 27.90%28.45B | 23.94%7.83B | 34.16%7.71B | 28.28%6.87B |
Cost of revenue | 0.00%4.06B | 3.61%16.97B | 1.34%4.65B | -7.54%4.05B | 7.67%4.21B | 15.97%4.06B | 24.15%16.38B | 23.64%4.59B | 27.79%4.38B | 22.85%3.91B |
Gross profit | 0.00%2.81B | 1.46%12.25B | -5.28%3.08B | -5.70%3.14B | 8.70%3.22B | 11.03%2.81B | 33.37%12.07B | 24.37%3.25B | 43.58%3.33B | 36.24%2.96B |
Operating expense | 0.00%1.66B | 4.50%7.37B | -0.91%1.97B | 5.87%1.96B | 6.98%1.77B | 7.15%1.66B | 7.50%7.05B | 3.22%1.99B | 17.95%1.85B | 6.07%1.66B |
Selling and administrative expenses | ---- | 4.50%7.37B | ---- | ---- | ---- | ---- | 7.50%7.05B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 3.69%3.37B | ---- | ---- | ---- | ---- | 7.93%3.25B | ---- | ---- | ---- |
-General and administrative expense | ---- | 5.20%3.99B | ---- | ---- | ---- | ---- | 7.15%3.8B | ---- | ---- | ---- |
Operating profit | 0.00%1.15B | -2.81%4.88B | -12.20%1.1B | -20.20%1.18B | 10.88%1.45B | 17.17%1.15B | 101.36%5.02B | 84.12%1.26B | 97.28%1.48B | 113.04%1.31B |
Net non-operating interest income (expenses) | 0.00%31.6M | 47.98%119.19M | 60.41%40.7M | -9.15%21.14M | 39.72%25.75M | 134.51%31.6M | 72.72%80.54M | 66.91%25.37M | 90.73%23.27M | 68.87%18.43M |
Non-operating interest income | 0.00%39.68M | 32.58%153.25M | 39.16%49.95M | -5.05%29.63M | 27.38%33.99M | 82.00%39.68M | 80.53%115.59M | 76.27%35.89M | 93.55%31.21M | 78.51%26.69M |
Non-operating interest expense | 0.00%8.08M | -2.81%34.06M | -12.09%9.25M | 6.95%8.5M | -0.18%8.24M | -2.98%8.08M | 101.47%35.04M | 103.86%10.52M | 102.32%7.95M | 104.59%8.25M |
Net investment income | 0.00%186.91M | 49.76%305.64M | 667.28%94.05M | 52.92%-73.1M | -27.18%97.78M | -22.65%186.91M | 9.84%204.08M | -118.09%-16.58M | -363.02%-155.27M | 1,922.78%134.27M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | 0 | 0 | 14,021.18%192.05M | 12,299.78%168.64M | |||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -1,032.83%-519.9M | -8.32%55.73M | |||||||
Less:Other special charges | ---- | 1,032.83%519.9M | ---- | ---- | ---- | ---- | 8.32%-55.73M | ---- | ---- | ---- |
Other non-operating income (expenses) | 0.00%31.69M | -22.03%84.75M | -65.48%2.59M | 19.50%27.67M | -39.20%22.8M | -21.83%31.69M | -24.32%108.7M | 125.43%7.5M | -56.04%23.16M | -25.96%37.5M |
Income before tax | 0.00%1.4B | -13.99%4.87B | -51.87%720.48M | -17.05%1.16B | 6.40%1.59B | 9.83%1.4B | 93.14%5.66B | 79.22%1.5B | 59.55%1.39B | 124.29%1.5B |
Income tax | 0.00%499.05M | 4.68%1.59B | 39.50%459.14M | -23.40%278.4M | -16.37%358.32M | 23.97%499.05M | 77.58%1.52B | 57.64%329.13M | 46.11%363.46M | 140.90%428.45M |
Net income | 0.00%902.2M | -20.86%3.28B | -77.62%261.33M | -14.81%876.9M | 15.52%1.24B | 3.31%902.2M | 99.57%4.14B | 86.42%1.17B | 64.90%1.03B | 118.27%1.07B |
Net income continuous operations | 0.00%902.2M | -20.86%3.28B | -77.62%261.33M | -14.81%876.9M | 15.52%1.24B | 3.31%902.2M | 99.57%4.14B | 86.42%1.17B | 64.90%1.03B | 118.27%1.07B |
Noncontrolling interests | 0.00%16.2M | 5.27%151.84M | 48.71%63.52M | -53.45%24.38M | 101.06%47.74M | -36.27%16.2M | 65.38%144.24M | -0.62%42.72M | 128.33%52.37M | 42.31%23.75M |
Net income attributable to the company | 0.00%886M | -21.80%3.13B | -82.42%197.81M | -12.74%852.52M | 13.58%1.19B | 4.50%886M | 101.07%4B | 92.83%1.13B | 62.48%977M | 120.95%1.05B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 0.00%886M | -21.80%3.13B | -82.42%197.81M | -12.74%852.52M | 13.58%1.19B | 4.50%886M | 101.07%4B | 92.83%1.13B | 62.48%977M | 120.95%1.05B |
Gross dividend payment | ||||||||||
Basic earnings per share | 0.00%48.88 | -19.14%173.81 | -80.47%12.05 | -10.10%47.35 | 17.54%65.53 | 9.06%48.88 | 108.10%214.95 | 102.13%61.71 | 67.95%52.67 | 127.27%55.75 |
Diluted earnings per share | 0.00%48.88 | -19.14%173.81 | -81.79%11.2373 | -10.10%47.35 | 17.51%65.5142 | 9.06%48.88 | 108.10%214.95 | 102.13%61.71 | 67.95%52.67 | 127.27%55.75 |
Dividend per share | 0 | -20.69%92 | -20.69%46 | 0 | -20.69%46 | 0 | 132.00%116 | 81.25%58 | 0 | 222.22%58 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |